Current management of carcinoma of the breast.

作者: Timothy J. Ebertein

DOI: 10.1097/00000658-199408000-00003

关键词:

摘要: Objective An in-depth retrospective review of the multidisciplinary approach to management carcinoma breast was done. The author reviewed previous trials and treatment from past present. indications contraindications surgical procedures, radiation therapy, systemic chemotherapy, hormonal therapy are discussed. Summary background data Carcinoma is one most common malignancies treated by practicing general or oncologic surgeon. disease best using a approach, combining efforts surgery, treatments. Understanding for each these modalities will provide surgeon up-to-date algorithms his/her patient. Conclusions provides comprehensive analysis breast. It emphasizes results discusses future controversies areas study.

参考文章(124)
Peters Wp, High-dose chemotherapy and autologous bone marrow support for breast cancer. Important advances in oncology. pp. 135- ,(1991)
C M Balch, S E Singletary, K I Bland, Clinical decision-making in early breast cancer. Annals of Surgery. ,vol. 217, pp. 207- 225 ,(1993)
J A Andersen, M Blichert-Toft, C K Axelsson, K W Andersen, C Rose, M Overgaard, H T Mouridsen, Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. Journal of The National Cancer Institute Monographs. pp. 19- 25 ,(1992)
S. Lakhani, M. D. Graham, J. C. Gazet, Breast conserving surgery in the management of in situ breast carcinoma. Ejso. ,vol. 17, pp. 258- 264 ,(1991)
K Straus, A Lichter, M Lippman, D Danforth, S Swain, K Cowan, H MacDonald, S Steinberg, T d'Angelo, None, Results of the National Cancer Institute early breast cancer trial. Journal of The National Cancer Institute Monographs. pp. 27- 32 ,(1992)
Jordan U. Gutterman, David V. Goeddel, Richard D. Williams, Axel Ullrich, Rik Derynck, Wendy H. Berger, Timothy S. Bringman, Synthesis of Messenger RNAs for Transforming Growth Factors α and β and the Epidermal Growth Factor Receptor by Human Tumors Cancer Research. ,vol. 47, pp. 707- 712 ,(1987)
S Paik, R Hazan, E R Fisher, R E Sass, B Fisher, C Redmond, J Schlessinger, M E Lippman, C R King, Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. Journal of Clinical Oncology. ,vol. 8, pp. 103- 112 ,(1990) , 10.1200/JCO.1990.8.1.103
D N Danforth, P A Findlay, H D McDonald, M E Lippman, C M Reichert, T d'Angelo, C R Gorrell, N L Gerber, A S Lichter, S A Rosenberg, Complete axillary lymph node dissection for stage I-II carcinoma of the breast. Journal of Clinical Oncology. ,vol. 4, pp. 655- 662 ,(1986) , 10.1200/JCO.1986.4.5.655
B Fisher, H Rockette, E R Fisher, D L Wickerham, C Redmond, A Brown, Leukemia in Breast Cancer Patients Following Adjuvant Chemotherapy or Postoperative Radiation The NSABP Experience Journal of Clinical Oncology. ,vol. 3, pp. 1640- 1658 ,(1985) , 10.1200/JCO.1985.3.12.1640